Movement Disorders (revue) - Curation (PubMed)

Index « MedMesh.i » - entrée « Serotonin Uptake Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonin Syndrome < Serotonin Uptake Inhibitors < Sertraline  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000985 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000D89 (2012) Tetsutaro Ozawa ; Kanako Sekiya ; Yumi Sekine ; Takayoshi Shimohata ; Masahiko Tomita ; Hideaki Nakayama ; Naotaka Aizawa ; Ryoko Takeuchi ; Takayoshi Tokutake ; Shinichi Katada ; Masatoyo NishizawaMaintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy.
001A61 (2010) Luís Fonseca ; Margarida Rodrigues ; Alvaro MachadoPsychogenic movement disorder after a venlafaxine-induced dystonia.
002B98 (2006) Deborah A. Hall [États-Unis] ; Elizabeth Berry-Kravis ; Randi J. Hagerman ; Paul J. Hagerman ; Cathlin D. Rice ; Maureen A. LeeheySymptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
002C80 (2006) Angelo Antonini [Italie] ; Silvana Tesei ; Anna Zecchinelli ; Paolo Barone ; Danilo De Gaspari ; Margherita Canesi ; Giorgio Sacilotto ; Nicoletta Meucci ; Claudio Mariani ; Gianni PezzoliRandomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.
002F32 (2005) Werner Poewe [Autriche]Treatment of dementia with Lewy bodies and Parkinson's disease dementia.
003048 (2005) Paulo S. Boggio [Brésil] ; Felipe Fregni ; Felix Bermpohl ; Carlos G. Mansur ; Moacyr Rosa ; Demetrio O. Rumi ; Egberto R. Barbosa ; Marina Odebrecht Rosa ; Alvaro Pascual-Leone ; Sérgio Paulo Rigonatti ; Marco A. Marcolin ; Maria Teresa Araujo SilvaEffect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
003081 (2005) Charles H. Adler [États-Unis]Nonmotor complications in Parkinson's disease.
003A33 (2002) Michael S. Okun [États-Unis] ; Kenneth M. Heilman ; Jerrold L. VitekTreatment of pseudobulbar laughter after gamma knife thalamotomy.
003A68 (2002) David J. Burn [Royaume-Uni]Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
003E95 (2000) S. Tesei [Italie] ; A. Antonini ; M. Canesi ; A. Zecchinelli ; C B Mariani ; G. PezzoliTolerability of paroxetine in Parkinson's disease: a prospective study.
004112 (1999) D. Mathen [Royaume-Uni] ; C D Marsden ; K P BhatiaSSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
004114 (1999) W. Meissner [Allemagne] ; T. Schmidt ; A. Kupsch ; T. Trottenberg ; T. LempertReversible leucopenia related to olanzapine.
004184 (1999) B. Safirstein [États-Unis] ; L M Shulman ; W J WeinerSuccessful treatment of hemichorea with olanzapine.
004272 (1999) I H Richard [États-Unis] ; A. Maughn ; R. KurlanDo serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.
004317 (1998) J M Brotchie [Royaume-Uni]Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease.
004345 (1998) I M Bronner [Pays-Bas] ; J A VannesteComplex movement disorder associated with fluvoxamine.
004494 (1998) R. Kurlan [États-Unis]Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome.
004529 (1997) M. Poyurovsky [Israël] ; M. Schneidman ; A. WeizmanSuccessful treatment of fluoxetine-induced dystonia with low-dose mianserin.
004595 (1997) R A Hauser [États-Unis] ; T A ZesiewiczSertraline for the treatment of depression in Parkinson's disease.
004618 (1997) E. Perucca ; E. Marchioni ; D. Soragna ; F. SavoldiFluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Serotonin Uptake Inhibitors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Serotonin Uptake Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Serotonin Uptake Inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024